Updated Jul 16, 2026 · Last SEC filing 2026-06-18
Arcutis Biotherapeutics, Inc. (ARQT) has filed 18 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-18. 2 Form 8-K material event filings were reported by ARQT in the last 90 days. 11 Form 144 notices of proposed sale were filed for ARQT stock. InsiderAlpha tracks every ARQT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001787306 |
| Form 4 filings (90d) | 18 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 11 |
| Latest Form 4 filing | 2026-06-18 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Welgus Howard G. | Director | S — Open-market sale | 635 | $25.67 | $16K | SEC | |
| Welgus Howard G. | Director | M — Option exercise | 822 | $6.52 | $5K | SEC | |
| Welgus Howard G. | Director | S — Open-market sale | 4.1K | $24.41 | $100K | SEC | |
| Welgus Howard G. | Director | M — Option exercise | 2.3K | $8.63 | $19K | SEC | |
| Welgus Howard G. | Director | M — Option exercise | 1.0K | $7.51 | $8K | SEC | |
| LIN SUE-JEAN | Director | S — Open-market sale | 4.9K | $24.38 | $121K | SEC | |
| Leonard Keith R | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Curran Terrie | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Heron Patrick J | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Gilbert Halley E | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Munshi Amit | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Krishnamohan Neha | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| LIN SUE-JEAN | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Welgus Howard G. | Director | A — Grant or award | 5.8K | $0.00 | — | SEC | |
| Burnett Patrick | See Remarks | S — Open-market sale | 222 | $21.05 | $5K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Arcutis Biotherapeutics, Inc. (ARQT). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Welgus Howard G. | 11 | $313K |
| Heron Patrick J | 3 | — |
| LIN SUE-JEAN | 3 | $121K |
| Burnett Patrick | 2 | $21K |
| Munshi Amit | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ARQT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ARQT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.